We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Global Robotic Lab Systems Market Reaches USD 8.8 Billion

By LabMedica International staff writers
Posted on 05 Jun 2017
Print article
The size of the global robotic laboratory automation systems market has reached USD 8.8 billion, with its future growth likely to be driven by an imbalance between the high demand for diagnostics and the lack of supply of qualified technicians. These are the latest findings of Kalorama Information, (New York, NY, USA), an independent medical market research firm.

According to Kalorama, most laboratories performing medical sample analyses continue to use manual distribution systems, with labor still accounting for about 60% of the cost of lab services. Robotic technology can be harnessed to completely automate the workflow process. A number of laboratory processes are suited for robotic automation, particularly those that involve repetitive movements, such as pick and place; heating and cooling specimens; as well as mixing, shaking, and testing specimens.

Laboratory robots can manage specimen tubes, prepare them for testing, and allow for sample tracking throughout the testing process, from collection to results. The systems have various modules comprising several units, such as decappers, sorters, centrifuges, analyzers, and refrigerators, that participate in sample preparation, transport to analytical instruments — such as hematology, chemistry and immunoassay analyzers — and post-analytical storage.

Since commercial off-the-shelf (OTS) systems do not exist for many complex and proprietary lab operations, task-targeted robotic systems are custom designed and configured for specific applications, often pre- and post-analytical processes, in order to eliminate any inconsistencies and shorten the time for technicians waiting to get their desired test results.

However, in comparison with manufacturing and service industries, diagnostic laboratories lag behind in utilizing large-scale industrial robotics and automation for productivity, capacity, and quality improvements. In recent years, considerable progress has been made in automation and robotization of analytical separation and processing, although the progress made in automating wet lab workflows has been comparatively much slower, largely due to the lack of available tools.

“More than two-thirds of clinical decisions are based on laboratory test results, and new tests are developed constantly. But a shrinking field of qualified laboratory personnel, while demand grows requires something to handle the tasks created,” said Bruce Carlson, Publisher of Kalorama Information. “Many laboratories are constrained by tight budgets and limited resources. This often makes purchasing, replacing, or even expanding laboratory robotics and automation a daunting endeavor.”

Related Links
Kalorama Information

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.